Proven effective against SARS-CoV-2 on hard non-porous surfaces
Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs
Enhanced Efficacy Claims - Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
Excellent Material Compatibility - Compatible with most non-porous, hard surfaces commonly used in clinical settings
2-minute universal contact time for bacteria, viruses, and pathogenic fungi
